Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

CD1d(hi)CD5⁺ B cells differentiate into antibody-secreting cells under the stimulation with calreticulin fragment.

Zhang T, Xia Y, Zhang L, Bao W, Hong C, Gao XM.

Protein Cell. 2013 Nov;4(11):872-81. doi: 10.1007/s13238-013-3062-5. Epub 2013 Nov 10.

2.

Recombinant murine calreticulin fragment 39-272 expands CD1d(hi)CD5+ IL-10-secreting B cells that modulate experimental autoimmune encephalomyelitis in C57BL/6 mice.

Hong C, Zhang T, Gao XM.

Mol Immunol. 2013 Oct;55(3-4):237-46. doi: 10.1016/j.molimm.2013.02.003. Epub 2013 Mar 21.

PMID:
23523122
3.

CD1d(hi)CD5+ B cells expanded by GM-CSF in vivo suppress experimental autoimmune myasthenia gravis.

Sheng JR, Quan S, Soliven B.

J Immunol. 2014 Sep 15;193(6):2669-77. doi: 10.4049/jimmunol.1303397. Epub 2014 Aug 18.

4.

TLR4 supports the expansion of FasL+CD5+CD1dhi regulatory B cells, which decreases in contact hypersensitivity.

Wang K, Tao L, Su J, Zhang Y, Zou B, Wang Y, Zou M, Chen N, Lei L, Li X.

Mol Immunol. 2017 Jul;87:188-199. doi: 10.1016/j.molimm.2017.04.016. Epub 2017 May 12.

PMID:
28505514
5.

B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells.

Jin G, Hamaguchi Y, Matsushita T, Hasegawa M, Le Huu D, Ishiura N, Naka K, Hirao A, Takehara K, Fujimoto M.

J Allergy Clin Immunol. 2013 Jun;131(6):1674-82. doi: 10.1016/j.jaci.2013.01.044. Epub 2013 Mar 25.

PMID:
23534976
6.

Cd1d regulates B cell development but not B cell accumulation and IL10 production in mice with pathologic CD5(+) B cell expansion.

Palmer VL, Nganga VK, Rothermund ME, Perry GA, Swanson PC.

BMC Immunol. 2015 Nov 4;16:66. doi: 10.1186/s12865-015-0130-z.

7.

IL-10 derived from CD1dhiCD5⁺ B cells regulates experimental autoimmune myasthenia gravis.

Sheng JR, Quan S, Soliven B.

J Neuroimmunol. 2015 Dec 15;289:130-8. doi: 10.1016/j.jneuroim.2015.10.023. Epub 2015 Oct 31.

PMID:
26616882
8.

Human mesenchymal stem cells upregulate CD1dCD5(+) regulatory B cells in experimental autoimmune encephalomyelitis.

Guo Y, Chan KH, Lai WH, Siu CW, Kwan SC, Tse HF, Wing-Lok Ho P, Wing-Man Ho J.

Neuroimmunomodulation. 2013;20(5):294-303. doi: 10.1159/000351450. Epub 2013 Jul 27.

PMID:
23899693
9.

The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals.

Yanaba K, Bouaziz JD, Matsushita T, Tsubata T, Tedder TF.

J Immunol. 2009 Jun 15;182(12):7459-72. doi: 10.4049/jimmunol.0900270.

10.

Ligation of TLR7 on CD19(+) CD1d(hi) B cells suppresses allergic lung inflammation via regulatory T cells.

Khan AR, Amu S, Saunders SP, Hams E, Blackshields G, Leonard MO, Weaver CT, Sparwasser T, Sheils O, Fallon PG.

Eur J Immunol. 2015 Jun;45(6):1842-54. doi: 10.1002/eji.201445211. Epub 2015 Apr 14.

11.

Regulatory B cells in skin and connective tissue diseases.

Fujimoto M.

J Dermatol Sci. 2010 Oct;60(1):1-7. doi: 10.1016/j.jdermsci.2010.08.010. Epub 2010 Sep 15. Review.

PMID:
20832998
12.

Autocrine stimulation of IL-10 is critical to the enrichment of IL-10-producing CD40(hi)CD5(+) regulatory B cells in vitro and in vivo.

Kim HS, Lee JH, Han HD, Kim AR, Nam ST, Kim HW, Park YH, Lee D, Lee MB, Park YM, Kim HS, Kim YM, You JC, Choi WS.

BMB Rep. 2015 Jan;48(1):54-9.

13.

Functional analysis of recombinant calreticulin fragment 39-272: implications for immunobiological activities of calreticulin in health and disease.

Hong C, Qiu X, Li Y, Huang Q, Zhong Z, Zhang Y, Liu X, Sun L, Lv P, Gao XM.

J Immunol. 2010 Oct 15;185(8):4561-9. doi: 10.4049/jimmunol.1000536. Epub 2010 Sep 20.

14.

Estrogen induces normal murine CD5+ B cells to produce autoantibodies.

Ansar Ahmed S, Dauphinée MJ, Montoya AI, Talal N.

J Immunol. 1989 Apr 15;142(8):2647-53.

PMID:
2467934
15.

Suppression of autoimmunity by CD5(+) IL-10-producing B cells in lupus-prone mice.

Baglaenko Y, Manion KP, Chang NH, Loh C, Lajoie G, Wither JE.

Genes Immun. 2015 Jul-Aug;16(5):311-20. doi: 10.1038/gene.2015.17. Epub 2015 May 14.

PMID:
25973757
16.

Purification and immunophenotypic characterization of murine B10 B cells.

Hong C, Gao XM.

Methods Mol Biol. 2014;1190:35-44. doi: 10.1007/978-1-4939-1161-5_3.

PMID:
25015271
17.

Estrogen-induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B cells.

Bodhankar S, Wang C, Vandenbark AA, Offner H.

Eur J Immunol. 2011 Apr;41(4):1165-75. doi: 10.1002/eji.201040992. Epub 2011 Mar 17.

18.

CD43-, but not CD43+, IL-10-producing CD1dhiCD5+ B cells suppress type 1 immune responses during Chlamydia muridarum genital tract infection.

Moore-Connors JM, Kim HS, Marshall JS, Stadnyk AW, Halperin SA, Wang J.

Mucosal Immunol. 2015 Jan;8(1):94-106. doi: 10.1038/mi.2014.45. Epub 2014 Jun 18.

PMID:
24938746
19.

A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses.

Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF.

Immunity. 2008 May;28(5):639-50. doi: 10.1016/j.immuni.2008.03.017.

20.

Retinoic acid and α-galactosylceramide regulate the expression of costimulatory receptors and transcription factors responsible for B cell activation and differentiation.

Chen Q, Mosovsky KL, Ross AC.

Immunobiology. 2013 Dec;218(12):1477-87. doi: 10.1016/j.imbio.2013.05.003. Epub 2013 May 20.

Supplemental Content

Support Center